ALLIANCEBERNSTEIN L.P. - PROGENICS PHARMACEUTICALS IN ownership

PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 153 filers reported holding PROGENICS PHARMACEUTICALS IN in Q3 2018. The put-call ratio across all filers is 1.25 and the average weighting 0.1%.

Quarter-by-quarter ownership
ALLIANCEBERNSTEIN L.P. ownership history of PROGENICS PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2020$4,730,000
+63.0%
1,244,815
+118.4%
0.00%
+50.0%
Q4 2019$2,901,000
+380.3%
570,002
+377.0%
0.00%
Q3 2019$604,000
-29.3%
119,502
-13.7%
0.00%
-100.0%
Q2 2019$854,000
+91.9%
138,452
+44.3%
0.00%
Q1 2019$445,000
+30.1%
95,952
+17.9%
0.00%
Q4 2018$342,000
-32.9%
81,3520.0%0.00%
Q3 2018$510,000
-22.0%
81,3520.0%0.00%
Q2 2018$654,000
-7.4%
81,352
-14.1%
0.00%
-100.0%
Q1 2018$706,000
+25.4%
94,6520.0%0.00%
Q4 2017$563,000
-19.2%
94,6520.0%0.00%
-100.0%
Q3 2017$697,000
+8.4%
94,6520.0%0.00%
Q2 2017$643,000
-71.7%
94,652
-60.6%
0.00%
-100.0%
Q1 2017$2,270,000
-42.1%
240,432
-47.0%
0.00%
-33.3%
Q4 2016$3,921,000
+468.3%
453,842
+316.6%
0.00%
+200.0%
Q3 2016$690,000
+50.0%
108,9520.0%0.00%
Q2 2016$460,000
-27.1%
108,952
-24.7%
0.00%
-100.0%
Q1 2016$631,000
+0.5%
144,652
+41.1%
0.00%0.0%
Q4 2015$628,000
+7.9%
102,482
+0.7%
0.00%
Q3 2015$582,000
-23.3%
101,7520.0%0.00%
-100.0%
Q2 2015$759,000
+39.5%
101,752
+11.8%
0.00%
Q1 2015$544,000
-20.9%
91,0520.0%0.00%
-100.0%
Q4 2014$688,000
+45.5%
91,0520.0%0.00%
Q3 2014$473,000
+20.7%
91,0520.0%0.00%
Q2 2014$392,000
+69.7%
91,052
+61.1%
0.00%
Q1 2014$231,000
-5.3%
56,523
+23.4%
0.00%
Q4 2013$244,000
-13.5%
45,823
-18.4%
0.00%
Q3 2013$282,000
-4.7%
56,123
-15.5%
0.00%
Q2 2013$296,00066,4270.00%
Other shareholders
PROGENICS PHARMACEUTICALS IN shareholders Q3 2018
NameSharesValueWeighting ↓
Phocas Financial Corp. 1,033,328$6,376,0000.68%
ARDSLEY ADVISORY PARTNERS LP 650,000$4,011,0000.63%
Worth Venture Partners, LLC 138,357$853,0000.47%
RICE HALL JAMES & ASSOCIATES, LLC 2,242,503$13,836,0000.46%
HIGHLAND CAPITAL MANAGEMENT LP 716,880$4,423,0000.26%
FARALLON CAPITAL MANAGEMENT LLC 5,543,386$34,203,0000.22%
Point72 Asset Management, L.P. 5,858,749$36,148,0000.19%
PINNACLE ASSOCIATES LTD 1,298,723$8,013,0000.19%
Fosun International Ltd 472,580$2,750,0000.18%
J. Goldman & Co LP 400,000$2,468,0000.17%
View complete list of PROGENICS PHARMACEUTICALS IN shareholders